Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
AstraZeneca
Express Scripts
Colorcon
Boehringer Ingelheim

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

TRELSTAR Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Trelstar, and when can generic versions of Trelstar launch?

Trelstar is a drug marketed by Allergan Sales Llc and is included in three NDAs. There is one patent protecting this drug.

This drug has forty-four patent family members in thirty-one countries.

The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.

Summary for TRELSTAR
Drug patent expirations by year for TRELSTAR
Drug Prices for TRELSTAR

See drug prices for TRELSTAR

Recent Clinical Trials for TRELSTAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bristol-Myers SquibbPhase 2
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
Sir Mortimer B. Davis - Jewish General HospitalPhase 2/Phase 3

See all TRELSTAR clinical trials

Synonyms for TRELSTAR
(6-D-Tryptophan)luteinizing hormone-releasing hormone
(D-Trp6)-GnRH
(D-Trp6)-LH-RH
[D-Trp6] LH-RH amide
[D-Trp6]-LH-RH
[D-Trp6]-LH-RH, >=97% (HPLC), powder
[D-Trp6]-Luteinizing hormone releasing hormone
08AN7WA2G0
124508-66-3
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide
57773-63-4
73T634
773T634
9081Y98W2V
AB01275488-01
AK552887
AKOS030213249
AKOS030529557
Arvekap
AY 25650
AY-25650
BIM 21003
BIM-21003
BN-52014
CHEBI:63633
CHEMBL1200554
CHEMBL1201334
CL 118,532
CL 118532
CL-118532
CS-5745
D-Trp6-LHRH
D-Tryptophan-LH-RH
D06247
D06248
DB06825
Debio-8206
Decapeptyl
Decapeptyl SR
Diferelin
Diphereline
Gonapeptyl
GTPL1177
HMS2090C17
HY-12551
Luteinizing hormone-releasing factor (pig), 6-D-tryptophan
MFCD00167541
Moapar
MolPort-016-581-127
NCGC00167301-01
Pamorelin
Pamorelin LA
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-GlyNH2
Salvacyl
SCHEMBL19712225
SCHEMBL5079698
Trellasar
Trelstar (TN)
Trelstar depot
Trelstar LA
Triptodur
TRIPTORELIN
Triptorelin (USAN/INN)
Triptorelin [USAN:INN:BAN]
Triptorelin Embonate
Triptorelin pamoate
Triptorelin pamoate (USAN)
Triptorelin pamoate [USAN]
Triptorelina
Triptorelina [INN-Spanish]
Triptoreline
Triptoreline [INN-French]
Triptorelinum
Triptorelinum [INN-Latin]
UNII-08AN7WA2G0
UNII-9081Y98W2V
VXKHXGOKWPXYNA-PGBVPBMZSA-N
Wy 42422
Wy 42462

US Patents and Regulatory Information for TRELSTAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000 RX Yes Yes   Start Trial   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001 RX Yes Yes   Start Trial   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 022437-001 Mar 10, 2010 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRELSTAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Dow
Johnson and Johnson
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.